Literature DB >> 6601726

Deletion mutants of Moloney murine leukemia virus which lack glycosylated gag protein are replication competent.

P Schwartzberg, J Colicelli, S P Goff.   

Abstract

A series of deletion mutations localized near the 5' end of the Moloney murine leukemia virus genome was generated by site-specific mutagenesis of cloned viral DNA. The mutants recovered from such deleted DNAs failed to synthesize the normal glycosylated gag protein gPr80gag. Two of the mutants made no detectable protein, and a third mutant, containing a 66-base pair deletion, synthesized an altered gag protein which was not glycosylated. All the mutants made normal amounts of the internal Pr65gag protein. The viruses were XC positive and replicated normally in NIH/3T3 cells as well as in lymphoid cell lines. These results indicate that the additional peptides of the glycosylated gag protein are encoded near the 5' end, that the glycosylated and internal gag proteins are synthesized independently, and that the glycosylated gag protein is not required during the normal replication cycle. In addition, the region deleted in these mutants apparently encodes no cis-acting function needed for replication. Thus, all essential sequences, including those for packaging viral RNA, must lie outside this area.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6601726      PMCID: PMC255156     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

1.  Infectious viral DNA of murine leukemia virus.

Authors:  D Smotkin; A M Gianni; S Rozenblatt; R A Weinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1975-12       Impact factor: 11.205

2.  Defective cleavage of a precursor polypeptide in a temperature-sensitive mutant of avian sarcoma virus.

Authors:  J M Rohrschneider; H Diggelmann; H Ogura; R R Friis; H Bauer
Journal:  Virology       Date:  1976-11       Impact factor: 3.616

3.  Murine B cell leukemia line with inducible surface immunoglobulin expression.

Authors:  C J Paige; P W Kincade; P Ralph
Journal:  J Immunol       Date:  1978-08       Impact factor: 5.422

4.  A mutant of Rous sarcoma virus with a conditional defect in the determinant(s) of viral host range.

Authors:  W S Mason; C Yeater
Journal:  Virology       Date:  1977-04       Impact factor: 3.616

5.  Ts pol mutants of avian sarcoma viruses: mapping and demonstration of single cycle recombinants.

Authors:  M C Alevy; P K Vogt
Journal:  Virology       Date:  1978-06-01       Impact factor: 3.616

6.  Purification and properties of an endo-beta-N-acetylglucosaminidase from Streptomyces griseus.

Authors:  A L Tarentino; F Maley
Journal:  J Biol Chem       Date:  1974-02-10       Impact factor: 5.157

7.  Thermolabile reverse transcriptase of a mammalian leukemia virus mutant temperature sensitive in its replication and sarcoma virus helper functions.

Authors:  S R Tronick; J R Stephenson; I M Verma; S A Aaronson
Journal:  J Virol       Date:  1975-12       Impact factor: 5.103

8.  Measurement of the sequence complexity of cloned Moloney murine leukemia virus 60 to 70S RNA: evidence for a haploid genome.

Authors:  H Fan; M Paskind
Journal:  J Virol       Date:  1974-09       Impact factor: 5.103

9.  The effect of helper virus on Abelson virus-induced transformation of lymphoid cells.

Authors:  N Rosenberg; D Baltimore
Journal:  J Exp Med       Date:  1978-04-01       Impact factor: 14.307

10.  Transfer of proteins across membranes. I. Presence of proteolytically processed and unprocessed nascent immunoglobulin light chains on membrane-bound ribosomes of murine myeloma.

Authors:  G Blobel; B Dobberstein
Journal:  J Cell Biol       Date:  1975-12       Impact factor: 10.539

View more
  53 in total

1.  N-terminal cleavage fragment of glycosylated Gag is incorporated into murine oncornavirus particles.

Authors:  R Fujisawa; F J McAtee; C Favara; S F Hayes; J L Portis
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

2.  Profile of Stephen P. Goff. Interview by Greg Williams.

Authors:  Stephen P Goff
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-13       Impact factor: 11.205

3.  Expression of enzymatically active reverse transcriptase in Escherichia coli.

Authors:  N Tanese; M Roth; S P Goff
Journal:  Proc Natl Acad Sci U S A       Date:  1985-08       Impact factor: 11.205

4.  Isolation of a recombinant murine leukemia virus utilizing a new primer tRNA.

Authors:  J Colicelli; S P Goff
Journal:  J Virol       Date:  1986-01       Impact factor: 5.103

5.  Monoclonal antibody to the amino-terminal L sequence of murine leukemia virus glycosylated gag polyproteins demonstrates their unusual orientation in the cell membrane.

Authors:  E A Pillemer; D A Kooistra; O N Witte; I L Weissman
Journal:  J Virol       Date:  1986-02       Impact factor: 5.103

6.  Efficient replication, integration, and packaging of retroviral vectors with modified long terminal repeats containing the packaging signal.

Authors:  S Joshi; A Van Brunschot; I Robson; A Bernstein
Journal:  Nucleic Acids Res       Date:  1990-07-25       Impact factor: 16.971

7.  Identification of gammaretroviruses constitutively released from cell lines used for human immunodeficiency virus research.

Authors:  Yasuhiro Takeuchi; Myra O McClure; Massimo Pizzato
Journal:  J Virol       Date:  2008-10-08       Impact factor: 5.103

8.  Identification of a sequence in the unique 5' open reading frame of the gene encoding glycosylated Gag which influences the incubation period of neurodegenerative disease induced by a murine retrovirus.

Authors:  J L Portis; G J Spangrude; F J McAtee
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

9.  A nonstructural gag-encoded glycoprotein precursor is necessary for efficient spreading and pathogenesis of murine leukemia viruses.

Authors:  A Corbin; A C Prats; J L Darlix; M Sitbon
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

10.  The neuroinvasiveness of a murine retrovirus is influenced by a dileucine-containing sequence in the cytoplasmic tail of glycosylated Gag.

Authors:  R Fujisawa; F J McAtee; K Wehrly; J L Portis
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.